Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
-
Published:2024-01
Issue:1
Volume:22
Page:50-62
-
ISSN:1544-1709
-
Container-title:The Annals of Family Medicine
-
language:en
-
Short-container-title:Ann Fam Med
Author:
Ebell Mark H.,Barry Henry C.,Baduni Kanishka,Grasso Gabrielle
Publisher
Annals of Family Medicine